Famlo is a medicine containing the active ingredient(s) famciclovir. On this page you will find out more about Famlo, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: famciclovir
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Famlo 250 mg film-coated tablet, 21
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Famciclovir is indicated for: ò Treatment of herpes zoster infection in adult patients who commence therapy within 72 hours of the onset of rash. Greatest benefit occurs if the drug is started within 48 hours. Efficacy has not been demonstrated in patients less than 50 years of age, although the occasional younger patient with severe herpes zoster may benefit from therapy with famciclovir. Herpes zoster infection is generally a milder condition in younger patients. ò Treatment of recurrent episodes of genital herpes in adults and adolescents 12 years of age and older. ò Suppression of recurrent genital herpes. ò Treatment of recurrent herpes labialis (cold sores) in immunocompetent adult patients.,Famciclovir is also indicated in immunocompromised patients for: ò Treatment of uncomplicated herpes zoster. ò Treatment of recurrent herpes simplex. ò Suppression of recurrent herpes simplex.
Table of characteristics
|Visual appearance||White round film coated tablets with FM on one side and 250 on the other side|
|Dosage Form||Tablet, film coated|
|Route of administration||Oral|
14 tablets: Prescription Only Medicine, or Prescription Animal Remedy
20 tablets: Prescription Only Medicine, or Prescription Animal Remedy
21 tablets: Prescription Only Medicine, or Prescription Animal Remedy
56 tablets: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 November 2017
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.